Deroy & Devereaux Private Investment Counsel Inc Biogen Inc. Transaction History

Deroy & Devereaux Private Investment Counsel Inc

$1.75 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$236.26 - $355.63 $206,727 - $311,176	-875 Closed	0 $0
Q3 2019 Oct 23, 2019	SELL	$217.44 - $243.88 $27,180 - $30,485	-125 Reduced 12.5%	875 $204,000
Q3 2017 Oct 25, 2017	BUY	$281.15 - $329.69 $281,150 - $329,690	1,000	1,000 $313,000

Others Institutions Holding BIIB

# of Institutions

1,022

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.89 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$988 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deroy & Devereaux Private Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Deroy & Devereaux Private Investment Counsel Inc with notifications on news.

Account